Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Study shows curcumin enhances antiretroviral delivery and reduces inflammation and oxidative stress in HIV, offering potential improvements in treating HIV-associated neurocognitive disorders.

Syncona to buy biotechnology company Freeline Therapeutics

Share this article Freeline leverages its AAV vector and capsid to deliver a functional copy of a therapeutic gene into human liver cells. Credit: crystal

November 23, 2023

Passive video use among toddlers can negatively affect language development

A new study from SMU psychologist Sarah Kucker and colleagues reveals that passive video use among toddlers can negatively affect language development, but their caregiver’s

February 21, 2024

Awakn Life Sciences Completes Sale of Awakn Clinics In Norway

As part of its business restructuring process and following its London clinics business sale, UK-based biotech Awakn Life Sciences Corp. AWKNF has sold its Norwegian clinics businesses in a management buyout transaction. Awakn will

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.